All trials - page: 178

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT02688062NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCIChinese Academy of Sciences
  • Age 18 - 60 yrs
  • Level T2-T12
  • AIS A
  • All
22PHASE1, PHASE2Biological/cell basedGeneral health
  • Adverse Events (AEs)
  • American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
  • Bowel and bladder control
  • Functional Independence Measure (FIM)
  • Magnetic Resonance Imaging (MRI) - conventional/anatomical and quantitative
  • Motor Evoked Potentials (MEPs)
  • Sensory evoked potentials (including mixed and dermatomal, mSSEPs, dSSEPs, contact heat/laser evoked potentials- CHEPS/LEPs)
24 months01 January 201623 February 20161
NCT02982811Intelligent Activity-based Client-centred TrainingPXL University CollegeParallel Assignment
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS
  • ≥ 3 months
Ended47Not ApplicableRehabilitationStanding/walking/mobility
  • Canadian Occupational Performance Measure
  • Short Form 36 (SF-36)
6 weeks01 March 201705 December 20164
NCT05756894Neurostimulation for Respiratory Function After Spinal Cord InjuryShirley Ryan AbilityLab
  • Age 18 - 85 yrs
  • Level C1-C5
  • AIS
  • ≥ 6 months
  • have respiratory deficits requiring ventilator use or demonstrate reduced vital capacity (less than 80%)
  • Have a caregiver or family member who is trained and willing to operate the ventilator during study visits
  • NOT be completely dependent on the support of a diaphragmatic pacer (24 hours per day)
  • NOT have history of head injury or stroke
  • NOT have history of seizures or epilepsy
  • NOT be taking medications that lower seizure threshold
  • NOT have metal in the skull including plates, shrapnel, cochlear implants or aneurysm clips
Recruiting10NATechnologyGeneral health
  • Motor Evoked Potentials (MEPs)
14 weeks28 February 202307 March 20231
NCT05693181Cord Blood Cells in Patients With Acute SCISklifosovsky Institute of Emergency Care
  • Age 18 - 75 yrs
  • Level C1-L5
  • AIS A, B
  • ≤ 7 days
  • have had decompressive, stabilizing surgery within 5 days post-SCI and prior to the first cell infusion
  • NOT have motor function in lower limbs
80PHASE1, PHASE2Biological/cell basedGeneral health
  • Adverse Events (AEs)
  • American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
  • Beck Depression Inventory (BDI)
  • Short Form 36 (SF-36)
12 months05 December 202220 January 20232
NCT05637775DiSCIoser: Improving Arm Sensorimotor Functions After Spinal Cord Injury Via Brain-Computer Interface TrainingI.R.C.C.S. Fondazione Santa Lucia
  • Age 18 - 70 yrs
  • Level C1-T1
  • AIS A, B, C, D
  • 30 days - 90 days
  • be at least 30 days but not more than 90 days after cervical SCI
  • NOT have an upper extremity motor score of 40 or greater
Ended30NATechnologyArm/hand function
  • Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
  • International Spinal Cord Injury Pain Classification (ISCIP)
  • Motor Evoked Potentials (MEPs)
  • Sensory evoked potentials (including mixed and dermatomal, mSSEPs, dSSEPs, contact heat/laser evoked potentials- CHEPS/LEPs)
  • Spinal Cord Independence Measure (SCIM)
48 hours15 November 202205 December 20221
NCT05593237Transcranial Magnetic Stimulation for Chronic Neuropathic PainUniversity of California, San Francisco
  • Age 18 - 80 yrs
  • Level C1-S5
  • AIS
  • All
  • meet criteria for chronic neuropathic pain
  • NOT have implanted device
Recruiting32NATechnologyMental health and psychosocial factors
  • Beck Depression Inventory (BDI)
  • Pain Visual Analog Scale (VAS)
6 months25 April 202225 October 20221